Time-resolved versus time-integrated portal dosimetry: the role of an object’s position with respect to the isocenter in volumetric modulated arc therapy

2016 ◽  
Vol 61 (10) ◽  
pp. 3969-3984 ◽  
Author(s):  
Lotte E J R Schyns ◽  
Lucas C G G Persoon ◽  
Mark Podesta ◽  
Wouter J C van Elmpt ◽  
Frank Verhaegen
2016 ◽  
Vol 15 (6) ◽  
pp. NP79-NP87 ◽  
Author(s):  
L.C.G.G. Persoon ◽  
M. Podesta ◽  
S.M.J.J.G. Nijsten ◽  
E.G.C. Troost ◽  
F. Verhaegen

Purpose: It is desirable that dosimetric deviations during radiation treatments are detected. Integrated transit planar dosimetry is commonly used to evaluate external beam treatments such as volumetric-modulated arc therapy. This work focuses on patient geometry changes which result in differences between the planned and the delivered radiation dose. Integrated transit planar dosimetry will average out some deviations. Novel time-resolved transit planar dosimetry compares the delivered dose of volumetric-modulated arc therapy to the planned dose at various time points. Four patient cases are shown where time-resolved transit planar dosimetry detects patient geometry changes during treatment. Methods: A control point to control point comparison between the planned dose and the treatment dose of volumetric-modulated arc therapy beams is calculated using the planning computed tomography and the kV cone-beam computed tomography of the day and evaluated with a time-resolved γ function. Results were computed for 4 patients treated with volumetric-modulated arc therapy, each showing an anatomical change: pleural effusion, rectal gas pockets, and tumor regression. Results: In all cases, the geometrical change was detected by time-resolved transit planar dosimetry, whereas integrated transit planar dosimetry showed minor or no indication of the dose discrepancy. Both tumor regression cases were detected earlier in the treatment with time-resolved planar dosimetry in comparison to integrated transit planar dosimetry. The pleural effusion and the gas pocket were detected exclusively with time-resolved transit planar dosimetry. Conclusions: Clinical cases were presented in this proof-of-principle study in which integrated transit planar dosimetry did not detect dosimetrically relevant deviations to the same extent time-resolved transit planar dosimetry was able to. Time-resolved transit planar dosimetry also provides results that can be presented as a function of arc delivery angle allowing easier interpretation compared to integrated transit planar dosimetry.


2021 ◽  
Vol 94 (1120) ◽  
pp. 20201014
Author(s):  
James L Bedford ◽  
Ian M Hanson

Objectives: In real-time portal dosimetry, thresholds are set for several measures of difference between predicted and measured images, and signals larger than those thresholds signify an error. The aim of this work is to investigate the use of an additional composite difference metric (CDM) for earlier detection of errors. Methods: Portal images were predicted for the volumetric modulated arc therapy plans of six prostate patients. Errors in monitor units, aperture opening, aperture position and path length were deliberately introduced into all 180 segments of the treatment plans, and these plans were delivered to a water-equivalent phantom. Four different metrics, consisting of central axis signal, mean image value and two image difference measures, were used to identify errors, and a CDM was added, consisting of a weighted power sum of the individual metrics. To optimise the weights of the CDM and to evaluate the resulting timeliness of error detection, a leave-pair-out strategy was used. For each combination of four patients, the weights of the CDM were determined by an exhaustive search, and the result was evaluated on the remaining two patients. Results: The median segment index at which the errors were identified was 87 (range 40–130) when using all of the individual metrics separately. Using a CDM as well as multiple separate metrics reduced this to 73 (35–95). The median weighting factors of the four metrics constituting the composite were (0.15, 0.10, 0.15, 0.00). Due to selection of suitable threshold levels, there was only one false positive result in the six patients. Conclusion: This study shows that, in conjunction with appropriate error thresholds, use of a CDM is able to identify increased image differences around 20% earlier than the separate measures. Advances in knowledge: This study shows the value of combining difference metrics to allow earlier detection of errors during real-time portal dosimetry for volumetric modulated arc therapy treatment.


2013 ◽  
Vol 52 (7) ◽  
pp. 1484-1489 ◽  
Author(s):  
Lucas C. G. G. Persoon ◽  
Ada G. T. M. Egelmeer ◽  
Michel C. Öllers ◽  
Sebastiaan M. J. J. G. Nijsten ◽  
Esther G. C. Troost ◽  
...  

2017 ◽  
Vol 12 (1) ◽  
Author(s):  
Luca Cozzi ◽  
Frank Lohr ◽  
Antonella Fogliata ◽  
Davide Franceschini ◽  
Fiorenza De Rose ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document